Navigation Links
B. Braun Medical Wins Two GHX 2009 Best in Class Awards
Date:6/4/2009

Recognized for Continued Market Leadership in Parenteral and Solutions/Nutritionals

BETHLEHEM, Pa., June 4 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun) today announced that it had received two 2009 GHX Best in Class Awards for achieving the highest year-over-year market share growth for distributed products in the Parenteral and Solutions/Nutritionals product categories for the 2008 calendar year.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )

B. Braun was among 30 leading medical-surgical product manufacturers recognized by GHX in five market segments and 35 product categories, ranging from cardiovascular devices to skin-care products. Winners were determined using GHX Market Intelligence reports that analyze national distributed sales transaction data.

"We are proud of our contribution to advancing patient outcomes with our infusion therapy products and services, which add to the growth of the market," said Caroll H. Neubauer, Chairman and CEO of B. Braun Medical Inc. "Our success in Parenteral and Solutions/Nutritionals, like all of our products, is built on delivering products that meet customer needs and supporting them with outstanding educational programs and customer service."

This is the second consecutive year GHX awarded B. Braun its Best in Class Awards in the Parenteral and Solutions/Nutritionals product categories.

"We are extremely pleased to honor B. Braun for its leadership in the Parenteral and Solutions/Nutritionals product categories," said Ed McCauley, General Manager, GHX Market Intelligence. "Despite the down economy, B. Braun grew 7.37 percent in the Parenteral category in 2008 while the overall market segment grew 7.45 percent, and 22.17 percent in the Solutions/Nutritionals category in 2008 while the overall market segment grew 16.4 percent."

With information provided by 27 of the nation's leading distributors, GHX Market Intelligence tracks and reports on more than $34 billion of distributed sales for medical-surgical and clinical laboratory supplies and devices. It is the only comprehensive source for accurate, detailed and timely data for the acute and alternate site healthcare markets, containing geographically relevant and competitive market share, size and average selling price reporting down to the three-digit ZIP code level.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise(R)" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.

About GHX

As the business hub for healthcare, GHX enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making. Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B Braun Medical Inc.; Becton, Dickinson & Co.; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Fisher Scientific International, Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc. For more information, visit www.ghx.com.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. B. Braun Anticipates Becoming First to Deliver FDA Approved 2g Cefazolin
2. NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) Technology
3. B. Braun Wins Premier Contract for Full Line of Dialysis Products
4. B. Braun Medical Inc. Launches Home Infusion Therapy Web Site
5. Be Green with B. Braun: Company Shares Expertise, Environmentally Responsible Products at ASHP 2008
6. Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008
7. B. Brauns DoseTrac(TM) Software: Making Connections to Better Manage IV Therapy
8. B. Braun Medical Inc. Launches Ambulatory Surgical Center Website
9. The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim
10. Scooter Store Executives to Deliver Power Wheelchair Donation to New Braunfels Car Crash Victim
11. 22nd Annual Braun Industries/ZOLL Medical EMT/Paramedic of the Year Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: